Martin is the Managing Director of Alterion Consulting Ltd, which he founded in 2010 to provide advice on scientific, business, fundraising and/o rlicensing strategy to start-up, biotech, pharma and venture capital companies.
Martin has more than 20 years of research, drug discovery, and development experience spanning from idea to approved medicine. Recent experience includes leadership of a GSK spinout company and CSO of BioCrea GmbH. He also spent more than 12 years in SmithKline Beecham and GSK where he led preclinical and clinical projects and held various management positions in the Neurosciences Therapeutic Area. Whilst at GSK, Martin was also a committee member and chair of the Academic Drug Discovery Initiative set up with Imperial College London. He is a trained electrophysiologist and highly cited expert on ion channels. He also brings a wealth of experience in externalisation, due diligence and deal-making with multiple successful deals completed for biotech and pharma.
Martin holds an MA in Natural Sciences (Biochemistry) from Cambridge University and completed his PhD at the MRC Laboratory of Molecular Biology in Cambridge UK.